Amphipathic β-cyclodextrin nanocarriers serve as intelligent delivery platform for anticancer drug

Hui Liu,Jian Chen,Xiufang Li,Zhiwei Deng,Peiru Gao,Jianbin Li,Tao Ren,Ling Huang,Yanjing Yang,Shian Zhong
DOI: https://doi.org/10.1016/j.colsurfb.2019.05.011
2019-08-01
Abstract:A novel glutathione-responsive (GSH-responsive) star-like amphiphilic polymer (C12H25)14-β-CD-(S-S-mPEG)7 (denoted as CCSP) was designed for efficient antitumor drug delivery. The amphiphilic β-cyclodextrin (β-CD) self-polymerize in water to form a sphere with a diameter of 40-50 nm. The secondary hydroxyl groups of β-CD were modified by dodecyl to form a hydrophobic core and the primary hydroxyl groups of β-CD were decorated with PEG through disulfide bond to form a hydrophilic shell. Since the hydrophobic cavity of β-CD was maintained, the hydrophobic core formed by dodecyl as well as cavity of β-CD provided CCSP with a loading content as high as 39.6 wt%. Importantly, DOX@CCSP exhibited low drug leakage and negligible cytotoxicity in non-reductive physiological environment, while it showed rapid release and high cytotoxicity in reductive tumorous environment via the breakage of disulfide bond. In view of the above-mentioned advantages of DOX@CCSP nanocarriers such as high loading content, proper size, favorable stimulus-response release performance and low leakage, it is believed that CCSP may offer great potential to be used as an intelligent nanocarrier for anticancer drug delivery.
What problem does this paper attempt to address?